Compounds > n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium

n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium and Hyperparathyroidism

n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium has been researched along with Hyperparathyroidism* in 2 studies

Reviews

1 review(s) available for n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium and Hyperparathyroidism

ArticleYear
    Annals of nuclear medicine, 2020, Volume: 34, Issue:9

    Topics: Choline; Humans; Hyperparathyroidism; Magnetic Resonance Imaging; Positron Emission Tomography Computed Tomography; Recurrence

2020

Other Studies

1 other study(ies) available for n-n-dimethyl-n-(18f)fluoromethyl-2-hydroxyethylammonium and Hyperparathyroidism

ArticleYear
Bilateral Lymphadenopathy After COVID Vaccine in 18F-Choline PET/MRI Performed for Hyperparathyroidism.
    Clinical nuclear medicine, 2023, Mar-01, Volume: 48, Issue:3

    We describe a case of a 56-year-old woman with primary hyperparathyroidism. 18F-Choline PET/MRI revealed incidental bilateral axillary lymphadenopathy with mild-moderate increased 18F-choline uptake. The patient had her first and third doses of COVID-19 vaccines from the left arm and second dose of vaccine from the right arm before PET examination.

    Topics: Choline; COVID-19; COVID-19 Vaccines; Female; Humans; Hyperparathyroidism; Lymphadenopathy; Magnetic Resonance Imaging; Middle Aged; Positron Emission Tomography Computed Tomography; Positron-Emission Tomography; Radiopharmaceuticals; Vaccines

2023